These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 29317406)
1. Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hočevar Lundberg IE; Bottai M; Tjärnlund A Ann Rheum Dis; 2018 Dec; 77(12):e91. PubMed ID: 29317406 [No Abstract] [Full Text] [Related]
2. The balance between clinical convenience and the new concepts of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. Kim HS Korean J Intern Med; 2021 Mar; 36(2):288-291. PubMed ID: 33725435 [No Abstract] [Full Text] [Related]
3. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667 [TBL] [Abstract][Full Text] [Related]
4. Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice. Hočevar A; Rotar Z; Krosel M; Čučnik S; Tomšič M Ann Rheum Dis; 2018 Dec; 77(12):e90. PubMed ID: 29237619 [No Abstract] [Full Text] [Related]
5. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Torre IG; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG; Ann Rheum Dis; 2017 Dec; 76(12):1955-1964. PubMed ID: 29079590 [TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of positively determined myositis antibodies in rheumatology: a retrospective monocentric analysis. Schumacher F; Zimmermann M; Kanbach M; Schulze W; Wollsching-Strobel M; Kroppen D; Stanzel SB; Majorski D; Windisch W; Strunk J; Berger M Arthritis Res Ther; 2024 Jul; 26(1):132. PubMed ID: 39014499 [TBL] [Abstract][Full Text] [Related]
7. First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort. Jinnin M; Ohta A; Ishihara S; Amano H; Atsumi T; Fujimoto M; Kanda T; Kawaguchi Y; Kawakami A; Mimori A; Mimori T; Mimura T; Muro Y; Sano H; Shimizu J; Takeuchi T; Tanaka Y; Yamamoto K; Sumida T; Kohsaka H; Ann Rheum Dis; 2020 Mar; 79(3):387-392. PubMed ID: 31694813 [TBL] [Abstract][Full Text] [Related]
8. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Garcia-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG; Arthritis Rheumatol; 2017 Dec; 69(12):2271-2282. PubMed ID: 29106061 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory myopathies: Adult and paediatric experts unite for new response criteria. Collison J Nat Rev Rheumatol; 2017 Jun; 13(6):321. PubMed ID: 28469265 [No Abstract] [Full Text] [Related]
10. Performance of the 2017 EULAR/ACR criteria for idiopathic inflammatory myopathies in a cohort of patients from Latin America. Valenzuela A; Torres M; Devés JD Medicine (Baltimore); 2022 Oct; 101(43):e31015. PubMed ID: 36316860 [TBL] [Abstract][Full Text] [Related]
11. Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR/ACR classification criteria. Hokkoku K; Yamamoto J; Uchida Y; Kondo A; Mukai T; Hatanaka Y; Kono H; Shimizu J; Kobayashi S; Sonoo M Medicine (Baltimore); 2024 Jan; 103(4):e37105. PubMed ID: 38277547 [TBL] [Abstract][Full Text] [Related]
12. Editorial: A New Classification of Adult Autoimmune Myositis. Senécal JL; Raynauld JP; Troyanov Y Arthritis Rheumatol; 2017 May; 69(5):878-884. PubMed ID: 28382651 [No Abstract] [Full Text] [Related]
13. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N; Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778 [TBL] [Abstract][Full Text] [Related]
14. Response to: Correspondence on "European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance" by Bossuyt Aringer M; Costenbader K; Leuchten N; Dörner T; Johnson SR Ann Rheum Dis; 2023 Aug; 82(8):e194. PubMed ID: 34509989 [No Abstract] [Full Text] [Related]
15. Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya. Lundberg IE; Tjärnlund A Ann Rheum Dis; 2018 Nov; 77(11):e78. PubMed ID: 29247124 [No Abstract] [Full Text] [Related]
16. 2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why? Malaviya AN Ann Rheum Dis; 2018 Nov; 77(11):e77. PubMed ID: 29170201 [No Abstract] [Full Text] [Related]
17. Does Leukopenia Influence Performance of the New European League Against Rheumatism/American College of Rheumatology Classification Criteria in an African-Descendent Population With Childhood-Onset Systemic Lupus Erythematosus? Comment on the Article by Aringer et al. Fonseca AR; Rodrigues MCF; Sztajnbok F; Land MGP; de Oliveira SKF Arthritis Rheumatol; 2020 Apr; 72(4):694-695. PubMed ID: 31769215 [No Abstract] [Full Text] [Related]
18. American College of Rheumatology/European League Against Rheumatism Sjögren's Syndrome Classification Criteria May Not Be Adequate for Extraglandular Disease and Necessitate Defining "Seronegative Sjögren's Syndrome": Comment on the Article by Shiboski et al. Tezcan ME; Kucuk H; Goker B Arthritis Rheumatol; 2017 Jun; 69(6):1341-1342. PubMed ID: 28245349 [No Abstract] [Full Text] [Related]
19. Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease' by Wallace Yardımcı GK; Yıldırım BES; Farisoğulları B; Kilic L; Karadag O Ann Rheum Dis; 2023 Dec; 82(12):e230. PubMed ID: 35817470 [No Abstract] [Full Text] [Related]
20. Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng Aringer M; Costenbader K; Dörner T; Johnson SR Ann Rheum Dis; 2022 Feb; 81(2):e23. PubMed ID: 32122907 [No Abstract] [Full Text] [Related] [Next] [New Search]